Hereditary angioedema:

Recent Updates:

Monograph added.

Indications for HAEGARDA:

Routine prophylaxis to prevent hereditary angioedema (HAE) attacks in adolescent and adult patients.

Adults and Children:

Rotate inj sites. Give by SC inj (eg, abdominal area, other SC sites). 60 IU/kg twice weekly (every 3 or 4 days).

Warnings/Precautions:

Discontinue and treat if severe hypersensitivity reactions occur. Have epinephrine inj available. Risk of thromboembolism events. Contains human plasma; monitor for possible infection transmission (eg, viruses, Creutzfeldt-Jakob disease agent). Pregnancy. Nursing mothers.

Pharmacologic Class:

C1 inhibitor.

Adverse Reactions:

Inj site reaction, hypersensitivity, nasopharyngitis, dizziness.

Note:

To report infections that may have been transmitted by Haegarda, call (866) 915-6958.

Generic Availability:

NO

How Supplied:

Single-use vial—1